These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 33196989)

  • 1. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
    Kasperkiewicz M
    Cell Stress Chaperones; 2021 Jan; 26(1):1-2. PubMed ID: 33196989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and Guillain-Barré syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism.
    Lucchese G; Flöel A
    Cell Stress Chaperones; 2020 Sep; 25(5):731-735. PubMed ID: 32729001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19.
    Kasperkiewicz M; Tukaj S
    Front Immunol; 2022; 13():1080786. PubMed ID: 36591225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases.
    Tukaj S; Zillikens D; Kasperkiewicz M
    Exp Dermatol; 2015 Aug; 24(8):567-71. PubMed ID: 25980533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
    Marino Gammazza A; Légaré S; Lo Bosco G; Fucarino A; Angileri F; Conway de Macario E; Macario AJ; Cappello F
    Cell Stress Chaperones; 2020 Sep; 25(5):737-741. PubMed ID: 32754823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms.
    Mantej J; Bednarek M; Sitko K; Świętoń M; Tukaj S
    Cell Stress Chaperones; 2021 Jul; 26(4):735-740. PubMed ID: 34080135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: A trigger of autoimmune diseases.
    Zebardast A; Hasanzadeh A; Ebrahimian Shiadeh SA; Tourani M; Yahyapour Y
    Cell Biol Int; 2023 May; 47(5):848-858. PubMed ID: 36740221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and autoimmune diseases.
    Liu Y; Sawalha AH; Lu Q
    Curr Opin Rheumatol; 2021 Mar; 33(2):155-162. PubMed ID: 33332890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SARS-CoV-2 as an instrumental trigger of autoimmunity.
    Dotan A; Muller S; Kanduc D; David P; Halpert G; Shoenfeld Y
    Autoimmun Rev; 2021 Apr; 20(4):102792. PubMed ID: 33610751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.
    Shah S; Danda D; Kavadichanda C; Das S; Adarsh MB; Negi VS
    Rheumatol Int; 2020 Oct; 40(10):1539-1554. PubMed ID: 32666137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association between COVID-19 and Guillain-Barré syndrome.
    Lunn MP; Carr AC; Keddie S; Pakpoor J; Pipis M; Willison HJ
    Brain; 2021 Jun; 144(5):e47. PubMed ID: 33822006
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
    Churilov LP; Normatov MG; Utekhin VJ
    Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 triggering autoimmune diseases.
    Mobasheri L; Nasirpour MH; Masoumi E; Azarnaminy AF; Jafari M; Esmaeili SA
    Cytokine; 2022 Jun; 154():155873. PubMed ID: 35461172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can the hyperthermia-mediated heat shock factor/heat shock protein 70 pathway dampen the cytokine storm during SARS-CoV-2 infection?
    Rébé C; Ghiringhelli F; Garrido C
    Br J Pharmacol; 2022 Nov; 179(21):4910-4916. PubMed ID: 33314076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.
    Adiguzel Y; Mahroum N; Muller S; Blank M; Halpert G; Shoenfeld Y
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):206-230. PubMed ID: 37505416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mimicry and autoimmunity in the time of COVID-19.
    Rojas M; Herrán M; Ramírez-Santana C; Leung PSC; Anaya JM; Ridgway WM; Gershwin ME
    J Autoimmun; 2023 Sep; 139():103070. PubMed ID: 37390745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies.
    Heck TG; Ludwig MS; Frizzo MN; Rasia-Filho AA; Homem de Bittencourt PI
    Clin Sci (Lond); 2020 Aug; 134(15):1991-2017. PubMed ID: 32749472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune complications of COVID-19.
    Yazdanpanah N; Rezaei N
    J Med Virol; 2022 Jan; 94(1):54-62. PubMed ID: 34427929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.